Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Bifurcation Lesions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global bifurcation lesions market size reached US$ 2.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2027, exhibiting a growth rate (CAGR) of 5.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

A bifurcation lesion refers to the narrowing of the coronary artery adjacent to the origin of a significant side branch (SB). It is prone to develop atherosclerotic plaque due to turbulent blood flow and high shear stress. It is treated using techniques like analysis, procedure duration, X-ray exposure, and long-term follow-up. Moreover, three-dimensional (3D) angiography and multi-slice computed tomography are utilized for measuring the bifurcation angles. With the advances in devices, imaging, adjunctive pharmacotherapy, and vascular access, the management of complex cases of bifurcation lesions is becoming possible worldwide.

Bifurcation Lesions Market Trends:

A significant rise in the occurrence of coronary artery disease (CAD) is increasing the risk of developing bifurcation lesions. This represents one of the key factors bolstering the market growth. Besides this, the approval of innovative devices, increasing insurance coverage, and improving imaging modalities are also strengthening the market growth. Moreover, the rising geriatric population, which is more likely to develop medical ailments, along with supportive initiatives undertaken by governments of various countries for reimbursement, is supporting the market growth. The increasing medical tourism, the escalating demand for minimally invasive (MI) procedures and the improving healthcare infrastructure are some of the other factors contributing to the growth of the market. Apart from this, the ongoing research on novel treatment techniques is driving the market. For instance, researchers are studying the effectiveness of the Szabo 2-stent technique for complex bifurcations lesions with high compromise risk or fatal consequences of SB occlusion. Furthermore, a wide range of clinical trials on stents and balloons, in confluence with the increasing number of skilled healthcare professionals, is anticipated to decrease risks associated with bifurcation lesions treatment and influence the market positively.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bifurcation lesions market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on types and application.

Breakup by Types:

  • One-Stent
  • Two-Stent
     

Breakup by Application:

  • Coronary Vascular
  • Peripheral Vascular
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.) and Terumo Corporation.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Types, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.) and Terumo Corporation
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Bifurcation Lesions Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Types
    6.1    One-Stent
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Two-Stent
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Application
    7.1    Coronary Vascular
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Peripheral Vascular
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9   SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10  Value Chain Analysis
11  Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12  Price Analysis
13  Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Boston Scientific Corporation
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Cardinal Health
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    Medtronic plc
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
        13.3.4    Spectranetics (Koninklijke Philips N.V.)
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
        13.3.5    Terumo Corporation
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis

List of Figures

Figure 1: Global: Bifurcation Lesions Market: Major Drivers and Challenges
Figure 2: Global: Bifurcation Lesions Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Bifurcation Lesions Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Bifurcation Lesions Market: Breakup by Types (in %), 2021
Figure 5: Global: Bifurcation Lesions Market: Breakup by Application (in %), 2021
Figure 6: Global: Bifurcation Lesions Market: Breakup by Region (in %), 2021
Figure 7: Global: Bifurcation Lesions (One-Stent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Bifurcation Lesions (One-Stent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Bifurcation Lesions (Two-Stent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Bifurcation Lesions (Two-Stent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Bifurcation Lesions (Coronary Vascular) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Bifurcation Lesions (Coronary Vascular) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Bifurcation Lesions (Peripheral Vascular) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Bifurcation Lesions (Peripheral Vascular) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: North America: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: North America: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: United States: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: United States: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Canada: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Canada: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Asia-Pacific: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Asia-Pacific: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: China: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: China: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Japan: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Japan: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: India: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: India: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: South Korea: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: South Korea: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Australia: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Australia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Indonesia: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Indonesia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Europe: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Europe: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Germany: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Germany: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: France: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: France: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United Kingdom: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United Kingdom: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Italy: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Italy: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Spain: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Spain: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Russia: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Russia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Latin America: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Latin America: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Brazil: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Brazil: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Mexico: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Mexico: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Middle East and Africa: Bifurcation Lesions Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Middle East and Africa: Bifurcation Lesions Market: Breakup by Country (in %), 2021
Figure 63: Middle East and Africa: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Global: Bifurcation Lesions Industry: SWOT Analysis
Figure 65: Global: Bifurcation Lesions Industry: Value Chain Analysis
Figure 66: Global: Bifurcation Lesions Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Bifurcation Lesions Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Bifurcation Lesions Market Forecast: Breakup by Types (in Million US$), 2022-2027
Table 3: Global: Bifurcation Lesions Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Bifurcation Lesions Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Bifurcation Lesions Market: Competitive Structure
Table 6: Global: Bifurcation Lesions Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global bifurcation lesions market was valued at US$ 2.2 Billion in 2021.

We expect the global bifurcation lesions market to exhibit a CAGR of 5.5% during 2022-2027.

The sudden outbreak of the COVID-19 pandemic had led to postponement of elective bifurcation lesions treatments to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment or healthcare professionals.

The growing prevalence of Coronary Artery Disease (CAD), along with the increasing focus on clinical trials on stents and balloons to decrease risks associated with bifurcation lesions treatment, is primarily driving the global bifurcation lesions market.

Based on the application, the global bifurcation lesions market can be bifurcated into coronary vascular and peripheral vascular. Currently, coronary vascular exhibits a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global bifurcation lesions market include Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.), and Terumo Corporation.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4